John Mackey

John Mackey

University of Alberta

H-index: 110

North America-Canada

About John Mackey

John Mackey, With an exceptional h-index of 110 and a recent h-index of 62 (since 2020), a distinguished researcher at University of Alberta, specializes in the field of cancer, clinical trials, drug development, photo acoustic remote sensing.

His recent articles reflect a diverse array of research interests and contributions to the field:

Associations between health-related fitness and patient-reported symptoms in newly diagnosed breast cancer patients

Abstract CT194: N-myristoylation inhibitor zelenirstat: New mechanistic insights and efficacy signals from a first in human phase I study

Label-free photon absorption remote sensing (PARS) histopathology in unprocessed tissues

Virtual histology with photon absorption remote sensing (PARS)

A first-in-human, open-label, phase I trial of daily oral zelenirstat, an NMT inhibitor, in patients with relapsed/refractory advanced cancer including gastrointestinal cancers.

Automated Whole Slide Imaging for Label-Free Histology using Photon Absorption Remote Sensing Microscopy

A First-in-Human, Open-Label, Phase I Dose Escalation Trial of Daily Oral Nmt Inhibitor Zelenirstat in Patients with Relapsed/Refractory B-Cell Lymphomas and Advanced Solid Tumors

Photon absorption remote sensing imaging of breast needle core biopsies is diagnostically equivalent to gold standard H&E histologic assessment

John Mackey Information

University

Position

Professor of Oncology

Citations(all)

54500

Citations(since 2020)

16509

Cited By

45625

hIndex(all)

110

hIndex(since 2020)

62

i10Index(all)

320

i10Index(since 2020)

224

Email

University Profile Page

Google Scholar

John Mackey Skills & Research Interests

cancer

clinical trials

drug development

photo acoustic remote sensing

Top articles of John Mackey

Associations between health-related fitness and patient-reported symptoms in newly diagnosed breast cancer patients

Journal of Sport and Health Science

2024/5/1

Abstract CT194: N-myristoylation inhibitor zelenirstat: New mechanistic insights and efficacy signals from a first in human phase I study

Cancer Research

2024/4/5

Label-free photon absorption remote sensing (PARS) histopathology in unprocessed tissues

2024/3/13

John Mackey
John Mackey

H-Index: 66

Parsin Haji Reza
Parsin Haji Reza

H-Index: 15

Virtual histology with photon absorption remote sensing (PARS)

arXiv preprint arXiv:2306.08583

2023/6/14

A first-in-human, open-label, phase I trial of daily oral zelenirstat, an NMT inhibitor, in patients with relapsed/refractory advanced cancer including gastrointestinal cancers.

2024/1/20

Automated Whole Slide Imaging for Label-Free Histology using Photon Absorption Remote Sensing Microscopy

IEEE Transactions on Biomedical Engineering

2024/1/17

A First-in-Human, Open-Label, Phase I Dose Escalation Trial of Daily Oral Nmt Inhibitor Zelenirstat in Patients with Relapsed/Refractory B-Cell Lymphomas and Advanced Solid Tumors

Blood

2023/11/28

Photon absorption remote sensing imaging of breast needle core biopsies is diagnostically equivalent to gold standard H&E histologic assessment

Current Oncology

2023/11/6

Weighted trajectory analysis and application to clinical outcome assessment

BioMedInformatics

2023/10/7

Endothelin receptor blocker reverses breast cancer–induced cardiac remodeling

Cardio Oncology

2023/10/1

Rationale and design of IMPACT-women: a randomised controlled trial of the effect of time-restricted eating, healthy eating and reduced sedentary behaviour on metabolic health …

British Journal of Nutrition

2023/9

P465: N-MYRISTOYLATION INHIBITION ABROGATES OXIDATIVE PHOSPHORYLATION TO TARGET ACUTE MYELOID LEUKEMIA STEM CELLS

HemaSphere

2023/8/1

TITAN trial: a randomized controlled trial of a cardiac rehabilitation care model in breast cancer

JACC: Advances

2023/8/1

Associations between health-related fitness and quality of life in newly diagnosed breast cancer patients

Breast cancer research and treatment

2023/6

Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis

BMC medicine

2023/5/11

Benefits of combined upper body exercise and compression therapy for breast cancer related lymphedema: a systematic review

2023/3/21

Exploration of photoacoustic remote sensing virtual histology in skin malignancies

2023/3/17

Toward automated deep learning-based virtual histological staining of slide-free total absorption photoacoustic remote sensing (TA-PARS)(Conference Presentation)

2023/3/9

Does cardiac imaging surveillance strategy influence outcomes in patients with early breast cancer?

Frontiers in Oncology

2023

Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trial

European Heart Journal-Cardiovascular Pharmacotherapy

2022/3

See List of Professors in John Mackey University(University of Alberta)

Co-Authors

academic-engine